239 top medical experts on Telomeric 22q13 Monosomy Syndrome across 28 countries and 22 U.S. states, including 57 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Telomeric 22q13 Monosomy Syndrome: Monosomy 22q13.3 syndrome (deletion 22q13.3 syndrome or Phelan-McDermid syndrome) is a chromosome microdeletion syndrome characterized by neonatal hypotonia, global developmental delay, normal to accelerated growth, absent to severely delayed speech, and minor dysmorphic features.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Synonyms: 22q13 Deletion Syndrome,  22q13.3 Deletion Syndrome,  Chromosome 22q13.3 Deletion Syndrome,  Deletion 22q13 Syndrome,  Deletion 22q13.3 Syndrome,  Monosomy 22q13,  Phelan-McDermid Syndrome


  

        

                    


    Computing Expert Listing ...